|
|
|
By Tim Sandle, Ph.D. | There has been limited guidance for assessing new or elevated impurity levels. To address this, the EMA has issued a "reflection paper" to consider what is needed for a safety evaluation. | |
|
|
|
| Resource Roadmap To Screening Success | e-book | Sartorius | Explore how tools streamline the development of cell-based therapies by optimizing processes, reducing costs, and accelerating manufacturing scalability. |
|
|
| Trends In Next-Generation Delivery Technologies | Article | Cytiva | Learn how lipid nanoparticles are enabling a new generation of engineered cell therapies with a push toward more complex cell engineering and gene editing for allogeneic therapies. |
|
|
|
| Engineering Approaches To Respiratory Drug Delivery | Case Study | By Cameron Kadleck, Jimmy Beaty, Matthew Ferguson, Ph.D., Lonza | Explore the material and performance properties of spray-dried and jet-milled mannitol for respiratory delivery of crystalline mannitol. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
